Amgen names President Robert Bradway to board

Fri, 10/14/2011 - 8:45am
The Associated Press

THOUSAND OAKS, Calif. (AP) — Biotechnology company Amgen Inc. said Thursday that it named President and Chief Operating Officer Robert Bradway as a board member.

Bradway, 48, began working at Amgen as its operations strategy vice president and was chief financial officer from April 2007 to May 2010.

With Bradway as a director, Amgen's board now has 13 directors.

Also Thursday, Amgen's board declared a regular quarterly dividend of 28 cents. The dividend is payable Dec. 8 to shareholders of record as of Nov. 17.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.